Brookfield Asset Management - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 182 filers reported holding PTC THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.65 and the average weighting 0.1%.

Quarter-by-quarter ownership
Brookfield Asset Management ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$561,043
-88.9%
13,795
-86.8%
0.00%
-89.5%
Q1 2023$5,053,745
+20.6%
104,330
-4.9%
0.02%
+18.8%
Q4 2022$4,189,501
+21.4%
109,759
+59.7%
0.02%
+23.1%
Q3 2022$3,450,000
+149.1%
68,735
+98.7%
0.01%
+116.7%
Q2 2022$1,385,000
-13.7%
34,585
-19.6%
0.01%0.0%
Q1 2022$1,605,00043,0100.01%
Other shareholders
PTC THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 7,235,196$162,140,7423.42%
Camber Capital Management LP 3,400,000$76,1942.51%
ARMISTICE CAPITAL, LLC 6,150,000$137,821,5002.11%
GREAT POINT PARTNERS LLC 500,000$11,205,0002.04%
COWEN AND COMPANY, LLC 799,511$17,917,0411.25%
GEORGE KAISER FAMILY FOUNDATION 45,816$6,491,2111.22%
SPHERA FUNDS MANAGEMENT LTD. 218,459$4,895,6660.89%
SECTORAL ASSET MANAGEMENT INC 187,016$4,191,0290.82%
Nebula Research & Development LLC 21,858$489,8380.26%
Phocas Financial Corp. 64,701$1,450,0000.21%
View complete list of PTC THERAPEUTICS INC shareholders